Investor Frazier Healthcare VII, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Frazier Healthcare VII, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2022-11-14 13D/A IMGO / Imago BioSciences Inc 2,971,935 3,902,207
2021-07-21 13D IMGO / Imago BioSciences Inc 2,971,935
2021-02-04 13G/A GRTS / Gritstone bio, Inc. 2,061,758 1,092,185
2020-10-29 13D/A ITRM / Iterum Therapeutics plc 1,557,158 1,557,158
2020-07-06 13D/A ITRM / Iterum Therapeutics plc 1,538,316 1,557,158
2020-06-16 13D/A ITRM / Iterum Therapeutics plc 1,538,316 1,538,316
2020-01-27 13D/A ITRM / Iterum Therapeutics plc 1,538,316 1,538,316
2019-02-14 13G GRTS / Gritstone bio, Inc. 2,061,758
2019-02-14 13G/A NBRV / Nabriva Therapeutics Plc 4,012,374 4,256,526
2018-11-13 13D/A CDTX / Cidara Therapeutics, Inc. 1,312,258 1,312,258
2018-08-03 13G NBRV / Nabriva Therapeutics Plc 4,012,374
2018-06-08 13D ITRM / Iterum Therapeutics plc 1,538,316
2018-02-26 13D/A CDTX / Cidara Therapeutics, Inc. 1,312,258 1,312,258
2016-03-29 13D CDTX / Cidara Therapeutics, Inc. 1,312,258